Recurrent respiratory papillomatosis: current and future perspectives

Area of Science:

• Otolaryngology
• Infectious Diseases
• Pulmonology

Background:

• Recurrent respiratory papillomatosis (RRP) is a benign upper aerodigestive tract disease caused by human papillomavirus (HPV).
• The disease course is unpredictable, varying from mild cases with spontaneous remission to aggressive forms with pulmonary spread and frequent surgical needs.
• RRP can lead to protracted illness, life-threatening airway compromise, and long-term complications affecting quality of life.

Purpose of the Study:

• To review the current understanding and management of recurrent respiratory papillomatosis.
• To explore alternative medical therapies and novel surgical approaches beyond standard debulking procedures.
• To highlight the potential role of human papillomavirus vaccination in improving treatment outcomes for RRP patients.

Main Methods:

• Review of existing literature on recurrent respiratory papillomatosis management.
• Analysis of outcomes from alternative medical therapies and surgical innovations.
• Discussion of emerging treatment strategies, including HPV vaccination.

Main Results:

• Standard surgical debulking is often required but associated with stenotic complications.
• Investigated alternative medical therapies have shown modest outcomes to date.
• Novel surgical instrumentation aims to mitigate long-term airway complications.

Conclusions:

• Improving treatment quality and patient outcomes for RRP remains a significant clinical challenge.
• Ongoing research into new therapies and surgical techniques is crucial.
• Human papillomavirus vaccination presents a potentially important future role in managing RRP.